{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001615219","name":"Decoy Therapeutics Inc.","summary":"Decoy Therapeutics Inc. (formerly Salarius Pharmaceuticals) is a pre-clinical stage biotechnology company developing peptide conjugate therapeutics via its proprietary IMP3ACT platform, which uses AI/ML and high-speed synthesis. The company focuses on infectious diseases and oncology, advancing Designable Multi-Antivirals (D-MAVs) targeting respiratory viruses, and retains legacy small molecule assets SP-3164 (protein degrader) and seclidemstat (SP-2577, protein inhibitor) from Salarius.","people":[],"products":[{"name":"IMP3ACT Platform","type":"platform","description":"Proprietary AI/ML-enabled platform for rapid design, optimization, and manufacture of peptide conjugate therapeutics."},{"name":"D-MAV (Designable Multi-Antivirals)","type":"platform","description":"Pipeline of peptide conjugate antiviral candidates targeting respiratory viruses, designed for adaptability to emerging threats."},{"name":"SP-3164","type":"platform","description":"Legacy Salarius targeted protein degrader small molecule; planned integration into peptide-based PROTACs (P-PROTACs)."},{"name":"Seclidemstat (SP-2577)","type":"service","description":"Legacy Salarius targeted protein inhibitor evaluated in clinical trial for myelodysplastic syndromes; seeking out-licensing."},{"name":"Pan-Coronavirus Antiviral","type":"platform","description":"Lead D-MAV candidate targeting coronaviruses, advancing toward Phase 2 human challenge trial, largely funded by non-dilutive grants."}],"partnerships":[{"partner_name":"The University of Texas MD Anderson Cancer Center (MDACC)","partnership_type":"development","description":"MDACC sponsored clinical trial evaluating SP-2577 in combination with azacytidine in myelodysplastic syndromes and CMML; enrollment ended December 2025.","start_date":null},{"partner_name":"Ladenburg Thalmann & Co. Inc.","partnership_type":"strategic","description":"Sole underwriter for the November 2025 public offering raising approximately $6.3 million net proceeds.","start_date":null},{"partner_name":"Equiniti Trust Company, LLC","partnership_type":"strategic","description":"Warrant agent for Series A, Series B, and pre-funded warrants issued in the November 2025 Offering.","start_date":null}],"affiliations":[],"origin":{"leaf":"621155cb94644ea13035deed5c335f8d4d07ac0d581e02857b7c84258fa5be76","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"d6b3b0732a99fdfb97554ec1eac6caac770e128f35dedf004683fccefdaf890f","parent":"1e8a620ede297e63bc933f0a27d4f77f50fc74a60606fa3f2755ee948ef7bf2b","source":"0001193125-26-134897","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":245,"hourly_limit":500,"remaining":255,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}